Cyclosporine ophthalmic solution

DRUG3 trials

Sponsors

Hanlim Pharm. Co., Ltd., Research Insight LLC

Conditions

Dry EyeDry Eye Syndromes

Phase 3

Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group

CompletedNCT01768312

Hanlim Pharm. Co., Ltd.Dry Eye Syndromes

Start: 2012-08-23End: 2013-07-31Updated: 2018-08-29

Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease

CompletedNCT02229955

Hanlim Pharm. Co., Ltd.Dry Eye Syndromes

Start: 2013-12-31End: 2014-07-31Updated: 2014-09-03

Phase 4

The COAT Trial: Cequa's Onset of Action Trial

CompletedNCT06482177

Research Insight LLCDry Eye

Start: 2023-10-12End: 2024-06-05Updated: 2024-07-01